Although ovarian VEGF signaling in women with T1DM is poorly characterized, systemic suppression of VEGF in T1DM suggests impaired ovarian angiogenesis and endothelial function, potentially contributing to ovarian dysfunction [42]. This evidence concerns the gene VEGFA and ovarian dysfunction.